review · Cureus
Cardiovascular diseases represent a growing global health challenge, driven significantly by lipid disorders and their contribution to atherosclerosis. Conditions such as coronary artery disease, myocardial infarction, and stroke are deeply linked to dyslipidaemia, which arises from an interplay of genetic factors, lifestyle choices, and metabolic irregularities. Atherosclerosis develops through complex interactions involving lipoproteins, cholesterol metabolism, and inflammatory pathways. Beyond standard lipid panels, newly identified biomarkers and advanced imaging tools offer improved ways to assess individual patient risk and guide therapies. Current clinical management combines lifestyle and dietary changes with established lipid-lowering drugs, such as statins and fibrates. Additionally, emerging treatments and precision medicine approaches that tailor interventions to a patient's genetic and molecular characteristics present promising avenues for enhanced cardiovascular care.
Cardiovascular conditions remain among the leading causes of illness and death across the globe. Understanding the complex mechanisms connecting abnormal blood fats, inflammation, and heart disease helps healthcare providers and public health authorities develop more targeted prevention strategies. Refining diagnostic tools and customising treatments to individual molecular profiles can ultimately lead to earlier detection, better patient care, and reduced healthcare burdens.
The work synthesises knowledge relevant to diagnostic developers and pharmaceutical companies working on cardiovascular health. It points towards applications in advanced imaging, biomarker-based diagnostic assays, and precision therapeutics tailored to individual genetic profiles. Because this is a broad review rather than an experimental study or product trial, the underlying concepts span from early-stage translational research to clinically applied therapies such as statins and fibrates.
AI-generated from the published abstract. Always read the original work before citing.
The increasing worldwide prevalence of cardiovascular diseases (CVDs) highlights the need to understand the complex relationships between lipid abnormalities and elevated cardiovascular risk. This review thoroughly investigates the complex terrain of lipid abnormalities, highlighting their crucial significance in developing CVDs. Dyslipidemia, which is closely connected to atherosclerosis, is a significant risk factor for CVDs, including coronary artery disease, myocardial infarction, and stroke. This review thoroughly examines the intricate relationship between lipoproteins, cholesterol metabolism, and the inflammatory cascade, providing a detailed comprehension of the mechanisms that contribute to atherogenic processes. An extensive analysis of the occurrence and distribution of lipid diseases worldwide indicates a concerning high frequency, which calls for a reassessment of public health approaches. Dyslipidemia is caused by a combination of genetic predispositions, lifestyle factors, and metabolic abnormalities, as supported by significant data. Moreover, investigating different types of lipoproteins and their specific functions in the development of atherosclerosis provides insight into the complex causes of CVDs. In addition to conventional lipid profiles, newly identified biomarkers and advanced imaging techniques are being carefully examined for their ability to improve risk classification and treatment strategies' effectiveness. From a critical perspective, the review thoroughly examines the current state of lipid-modifying medicines, specifically statins, fibrates, and new therapeutic approaches. The text discusses the emerging concept of precision medicine, which involves tailoring treatment approaches to individuals based on their genetic and molecular characteristics. This approach has the potential to improve treatment outcomes. In addition, this study critically assesses the effects of lifestyle changes and nutritional interventions on lipid homeostasis, offering a comprehensive view of preventive strategies. This review consolidates current viewpoints on lipid diseases and their complex correlation with cardiovascular risk. This review contributes to the ongoing cardiovascular disease prevention and management dialogue by clarifying the molecular mechanisms, exploring new therapeutic options, and considering broader societal implications.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.7759/cureus.51395
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
